APA
Azimi A., Hanaei S., Sahraian M. A., Mohammadifar M., Ramagopalan S. V. & Ghajarzadeh M. (20200731). Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. : Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
Chicago
Azimi Amirreza, Hanaei Sara, Sahraian Mohammad Ali, Mohammadifar Mehdi, Ramagopalan Sreeram V and Ghajarzadeh Mahsa. 20200731. Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. : Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
Harvard
Azimi A., Hanaei S., Sahraian M. A., Mohammadifar M., Ramagopalan S. V. and Ghajarzadeh M. (20200731). Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. : Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
MLA
Azimi Amirreza, Hanaei Sara, Sahraian Mohammad Ali, Mohammadifar Mehdi, Ramagopalan Sreeram V and Ghajarzadeh Mahsa. Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. : Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 20200731.